Clinical Trial Update: Genome Expression in Lymphoma, Leukemia and Multiple Myeloma

View source ↗

Summary

A completed clinical trial update detailing a genome expression study in leukemia, multiple myeloma, and lymphomas (Hodgkin and Non-Hodgkin).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Leukemia
• Multiple Myeloma
• Non-hodgkin Lymphoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Leukemia, Multiple Myeloma | Status: COMPLETED